NEWS

20 May 2014

Read more

14 May 2014

Read more

"Stop experimenting with drug prices", as was stated by Mr. Theodore Tryfon

14 November 2013

A profound appeal to stop experimenting with drug prices was made by the Vice President of the Panhellenic Association of Pharmaceutical Industries (PEF) Mr. Theodore Tryfon, to the leadership of the Greek Ministry of Health on Wednesday, November 13, at a Stat Bank event entitled "Health-Drugs-Beauty 2013".

Read more

"Greek pharmaceutical companies adhere strictly to international standards", states Professor Machairas

11 November 2013

The fact that the Greek Pharmaceutical Industry meets high production standards was highlighted by Professor Panagiotis Machairas, Biopharmaceutics & Pharmacokinetics, National & Kapodistrian University of Athens, in his speech at the 1st Greek National Conference on "Crisis Management in Healthcare".

Read more
Pharmaceutical expenditure cutbacks pose a great health risk to patients, as stated by leading representatives of the Greek Pharmaceutical sector

Pharmaceutical expenditure cutbacks pose a great health risk to patients, as stated by leading representatives of the Greek Pharmaceutical sector

09 November 2013

An appeal to increase pharmaceutical expenditure in order to ensure the patients's access to reliable and qualitative treatments was made by the leaders of the Pharma sector on Saturday, November 9, at the 1st Greek National Conference on "Crisis Management in the Pharmaceutical Sector".

Read more
ELPEN's strategic global expansion spearheaded by the ground-breaking device: Elpenhaler<sup>®</sup>

ELPEN's strategic global expansion spearheaded by the ground-breaking device: Elpenhaler®

31 October 2013

ELPEN drugs are exported to 60 countries worldwide, 27 of which are in Europe, with the primary aim to achieve further global expansion, spearheaded by Elpenhaler®, an original product, patented by the company's founder, Mr. Dimitrios Pentafragas.

Read more